Letronne, Florent <br/><br/>
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.  [electronic resource] 

 -  EBioMedicine  Jul 2016 
 - 278-292 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2352-3964 
<br/><br/><label>Standard No.: </label>10.1016/j.ebiom.2016.06.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAM Proteins--antagonists & inhibitors<br/>Alzheimer Disease--metabolism<br/>Amino Acid Sequence<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Brain--metabolism<br/>Cathepsin D--chemistry<br/>Cell Line, Tumor<br/>Down-Regulation--drug effects<br/>HEK293 Cells<br/>Humans<br/>Lysosomes--metabolism<br/>Macrolides--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Microscopy, Fluorescence<br/>Patch-Clamp Techniques<br/>Pepstatins--pharmacology<br/>RNA Interference<br/>RNA, Small Interfering--metabolism